These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30305679)

  • 1. Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma.
    Ho SY; Liu PH; Hsu CY; Hsia CY; Su CW; He YJ; Lee YH; Huang YH; Hou MC; Huo TI
    Sci Rep; 2018 Oct; 8(1):15074. PubMed ID: 30305679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metavir Fibrosis Stage in Hepatitis C-Related Hepatocellular Carcinoma and Association with Noninvasive Liver Reserve Models.
    Ho SY; Wang LC; Hsu CY; Liu PH; Hsia CY; Huang YH; Huo TI
    J Gastrointest Surg; 2020 Aug; 24(8):1860-1862. PubMed ID: 32424685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
    Ma J; Jiang Y; Gong G
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):428-34. PubMed ID: 23358121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.
    Gao H; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Qin R; Yan L; Xiao G
    Oncotarget; 2017 Jan; 8(3):4289-4300. PubMed ID: 28008144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma.
    Yu SJ; Lee JH; Chung GE; Lee CH; Cho EJ; Jang ES; Kwak MS; Kim YJ; Yoon JH; Jang JJ; Lee HS
    Korean J Hepatol; 2010 Dec; 16(4):389-96. PubMed ID: 21415583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
    Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
    Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
    Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
    Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
    J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV.
    Toyoda H; Tada T; Tachi Y; Hirai T; Yasuda S; Honda T; Hayashi K; Ishigami M; Goto H; Kumada T
    Antivir Ther; 2017; 22(3):185-193. PubMed ID: 27586087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Lee PC; Huang YH; Wu JC; Lin HC; Chiang JH; Lee SD
    J Clin Gastroenterol; 2006 Jul; 40(6):543-50. PubMed ID: 16825938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.
    Patel J; Yopp A; Waljee AK; Singal AG
    J Clin Gastroenterol; 2016 Feb; 50(2):175-9. PubMed ID: 26125462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Ho SY; Liu PH; Hsu CY; Hsia CY; Lee YH; Lee RC; Huang YH; Lee FY; Hou MC; Tsai YJ; Huo TI
    PLoS One; 2017; 12(7):e0180408. PubMed ID: 28672011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
    Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis B and minimally fibrotic liver.
    Kadri HS; Blank S; Wang Q; Kim KW; Fiel MI; Luan W; Hiotis SP
    Eur J Surg Oncol; 2013 Dec; 39(12):1371-6. PubMed ID: 24148650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.
    Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B
    Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.